Seller has based any recommendations to Buyer upon information that Seller considers reliable, but Seller makes no warranty as to any results Buyer might obtain in Buyer’s use(s) for the Product. If Buyer has a dispute with respect to an invoice, Buyer must notify Seller within seven (7) business days after the date of invoice. Thereafter, Buyer automatically approves the invoice. 7.

Seller has based any recommendations to Buyer upon information that Seller considers reliable, but Seller makes no warranty as to any results Buyer might obtain in Buyer’s use(s) for the Product. If Buyer has a dispute with respect to an invoice, Buyer must notify Seller within seven (7) business days after the date of invoice. Thereafter, Buyer automatically approves the invoice. 7.

Seller has based any recommendations to Buyer upon information that Seller considers reliable, but Seller makes no warranty as to any results Buyer might obtain in Buyer’s use(s) for the Product. If Buyer has a dispute with respect to an invoice, Buyer must notify Seller within seven (7) business days after the date of invoice. Thereafter, Buyer shall be deemed to have automatically approved the invoice. 7.

Seller has based any recommendations to Buyer upon information that Seller considers reliable, but Seller makes no warranty as to any results Buyer might obtain in Buyer’s use(s) for the Product. If Buyer has a dispute with respect to an invoice, Buyer must notify Seller within seven (7) business days after the date of invoice. Thereafter, Buyer automatically approves the invoice. 7.

Revenue expanded 7% to $814 million, driven by recent commercial investments and record performances in Distribution and Performance Products and Solutions Adjusted EPS increased 7% to $0.63 from $0.59 offsetting significantly higher raw material costs Attachment 7

Adjusted EPS increased 7% to $2.21, representing the 8th consecutive year of adjusted EPS growth a 7% increase from Attachment 7

A NR 989/2002 - ZMIENIONO §§ 4; 7 UST. 1, 2, 5; 9 UST. 2, 3, 4; 11 UST. 2, 5; 11A UST. 4; 12 UST. 2; 13 UST. 2; 17 UST. 2 UMOWY SPÓŁKI; 2 20.01.2010 R , REP. A NR 10344/2015, NOTARIUSZ TOMASZ CYGAN, KANCELARIA NOTARIALNA W WARSZAWIE, ZMIANA § 7 UST. 1 ORAZ § 7 UST. 3 UMOWY SPÓŁKI. 9 29.10.2015 R., KANCELARIA NOTARIALNA W WARSZAWIE, NOTARIUSZ TOMASZ CYGAN, REPERTORIUM A NR 15613/2015, ZMIANA §2, §4 UMOWY SPÓŁKI. 10 22.03.2021 R. 7.Data do jakiej została zawieszona ­­­­­­ Rubryka 2 ­ Organ nadzoru Rubryka 3 ­ Prokurenci 1 1.Nazwisko CIULĘBA 2.Imiona TOMASZ 3.Numer PESEL 77030712078 4.Rodzaj prokury PROKURA OBEJMUJĄCA UMOCOWANIE WYŁĄCZNIE DO DOKONYWANIA CZYNNOŚCI WSPÓLNIE Z CZŁONKIEM ZARZĄDU.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; disruptions or inefficiencies in our supply chain, logistics, or operations; changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change; fluctuations in raw material prices, quality and supply, and in energy prices and supply; demand for our products and services; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts and any recessionary conditions. See Attachment 3 for a definition and summary of special items and Attachment 7 for a summary of pro forma adjustments associated with the APM Acquisition. Attachment 7

* V0 @ 1.5 and 3.0mm FR PC/ABS failed 0% 20% 40% 60% 80% 100% 120% 140% Virex TB Clorox Broad Spectrum CaviCide SaniCloth Plus wipes FR PC/ABS failed FR PC/ABS failed FR PC/ABS failed FR PC / ABS (1.0% Strain) FR PC / ABS (1.5% Strain) Trilliant HC (1.0% strain) Trilliant HC (1.5% strain) FR PC/ABS failed 0% 20% 40% 60% 80% 100% 120% 140% Virex TB Clorox Broad Spectrum CaviCide SaniCloth Plus wipes FR PC/ABS failed FR PC/ABS failed FR PC/ABS failed FR PC / ABS (1.0% Strain) FR PC / ABS (1.5% Strain) Trilliant HC (1.0% strain) Trilliant HC (1.5% strain) TENSILE STRENGTH RETENTION AFTER 7 DAYS EXPOSURE Both materials were tested according to ASTM D543 for 7 days.